# ClinicalTrials.gov record NCT01796301

> PeptideScanner retained ClinicalTrials.gov record NCT01796301 at 2026-07-30T19:32:59.853Z. Its registry update date was 2022-11-29, and PeptideScanner's reviewed identity mapping was teriparatide.

- Evidence object: `story:clinicaltrials-gov-nct01796301-teriparatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2022-11-29
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct01796301-teriparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01796301-teriparatide-v1.json
- Content SHA-256: `b71eb3226bd68804e52a1d1d90763337512148b7a7cda8f0e108b9863e3698d2`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT01796301 ([`ctg-observation-nct01796301-2022-11-29-747811b32ba9`](#source-ctg-observation-nct01796301-2022-11-29-747811b32ba9))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT01796301 at 2026-07-30T19:32:59.853Z. Its registry update date was 2022-11-29, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct01796301-2022-11-29-747811b32ba9`](#source-ctg-observation-nct01796301-2022-11-29-747811b32ba9))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT01796301 at 2026-07-30T19:32:59.853Z. Its registry update date was 2022-11-29, and PeptideScanner's reviewed identity mapping was teriparatide. ([`ctg-observation-nct01796301-2022-11-29-747811b32ba9`](#source-ctg-observation-nct01796301-2022-11-29-747811b32ba9))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct01796301-2022-11-29-747811b32ba9`](#source-ctg-observation-nct01796301-2022-11-29-747811b32ba9))

## Sources

<a id="source-ctg-observation-nct01796301-2022-11-29-747811b32ba9"></a>
- **ClinicalTrials.gov record NCT01796301 · retained source version 2022-11-29:747811b32ba991a04549d37eecc20411ed95c6e216c1a1a4613eab66a57023e4** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT01796301) (`ctg-observation-nct01796301-2022-11-29-747811b32ba9`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT01796301." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct01796301-teriparatide-v1.json SHA-256: b71eb3226bd68804e52a1d1d90763337512148b7a7cda8f0e108b9863e3698d2.